Clinical Trial

SLC6A1-NDD Prospective Longitudinal Natural History Study

Study acronym: SPIRIT
Recruiting
View on ClinicalTrials.gov →
Summary
The overall objective of this prospective longitudinal natural history study is to collect clinical data to characterize and evaluate the natural course of SLC6A1-NDD and assess the feasibility of certain assessments for the purpose of conducting future clinical studies in patients with this disease.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-25
notable Trial sites expanded: 0 -> 3 locations 2026-07-25
Trial Details
NCT Number NCT07531511
Lead Sponsor UCB Biopharma SRL
Conditions SLC6A1 Neurodevelopmental Disorder (NDD), Developmental and Epileptic Encephalopathies (DEE)
Enrollment 60 participants
Start Date 2026-07-21
Primary Completion 2029-05-25 (estimated)
Study Completion 2029-05-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-31